Biosimilars for the Treatment of Retinal Diseases

被引：3
|
作者：
Hariprasad, Seenu M. [1 ]
Narayanan, Raja [2 ]
Sheth, Jay [3 ]
机构：
[1] Univ Chicago, Dept Ophthalmol & Visual Sci, 5841 S Maryland Ave,Room S-439, Chicago, IL 60637 USA
[2] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Serv, Kallam Anji Reddy Campus,LV Prasad Marg,Opp PVR, Hyderabad 500034, Telangana, India
[3] Surya Eye Inst & Res Ctr, Dept Vitreoretinal Serv, Aroto House,104,Purushottam Kheraj Rd, Mumbai 400080, Maharashtra, India
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2021年 / 52卷 / 05期
关键词：
LESSONS;
D O I：
10.3928/23258160-20210429-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：242 / 246
页数：5
相关论文
共 50 条
  • [1] Razumab-the role of biosimilars for the treatment of retinal diseases
    Desideri, L. Ferro
    Cutolo, C. A.
    Traverso, C. E.
    Nicolo, M.
    DRUGS OF TODAY, 2021, 57 (08) : 499 - 505
  • [2] An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review
    Hariprasad, Seenu M.
    Gale, Richard P.
    Weng, Christina Y.
    Ebbers, Hans C.
    Rezk, Mourad F.
    Tadayoni, Ramin
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (03) : 959 - 982
  • [3] An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review
    Seenu M. Hariprasad
    Richard P. Gale
    Christina Y. Weng
    Hans C. Ebbers
    Mourad F. Rezk
    Ramin Tadayoni
    Ophthalmology and Therapy, 2022, 11 : 959 - 982
  • [4] Biosimilars for Retinal Diseases: An Update
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Bandello, Francesco
    Kuppermann, Baruch D.
    Loewenstein, Anat
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 224 : 36 - 42
  • [5] Emerging biosimilars for retinal diseases
    Sharma, Ashish
    Parachuri, Nikulaa
    Kumar, Nilesh
    Bandello, Francesco
    Kuppermann, Baruch D.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2022, 17 (06) : 383 - 386
  • [6] Switching to biosimilars in the treatment of rheumatic diseases
    Yoo, Dae Hyun
    Choe, Jung-Yoon
    Shim, Seung Cheol
    Suh, Chang-Hee
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (07) : 557 - 571
  • [7] The role of biosimilars in the treatment of rheumatic diseases
    Doerner, Thomas
    Strand, Vibeke
    Castaneda-Hernandez, Gilberto
    Ferraccioli, Gianfranco
    Isaacs, John D.
    Kvien, Tore K.
    Martin-Mola, Emilio
    Mittendorf, Thomas
    Smolen, Josef S.
    Burmester, Gerd R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 322 - 328
  • [8] Biosimilars in the Treatment of Retinal Disease in the United States
    Vakharia, Priya S.
    Eichenbaum, David A.
    Baumal, Caroline R.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (06): : 362 - 366
  • [9] Commentary: Use of biosimilars for retinal diseases in India: Challenges and concerns
    Kumar, Aman
    Agarwal, Divya
    Kumar, Atul
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (02) : 357 - +
  • [10] Biosimilars approved for treatment of inflammatory rheumatological diseases
    Mahler, Stephen M.
    Wardiana, Andri
    Jones, Martina L.
    De Bakker, Christopher J.
    Graham, Garry G.
    Howard, Christopher B.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1043 - 1048
12345